SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-006023
Filing Date
2021-03-16
Accepted
2021-03-15 17:47:20
Documents
52
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 400824
2 ex31-1.htm EX-31.1 9171
3 ex32-1.htm EX-32.1 4872
  Complete submission text file 0001493152-21-006023.txt   2549409

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE lung-20200930.xml EX-101.INS 357151
5 XBRL SCHEMA FILE lung-20200930.xsd EX-101.SCH 43157
6 XBRL CALCULATION FILE lung-20200930_cal.xml EX-101.CAL 40309
7 XBRL DEFINITION FILE lung-20200930_def.xml EX-101.DEF 133799
8 XBRL LABEL FILE lung-20200930_lab.xml EX-101.LAB 276919
9 XBRL PRESENTATION FILE lung-20200930_pre.xml EX-101.PRE 205634
Mailing Address 350 W. 800 N. SUITE 214 SALT LAKE CITY UT 84103
Business Address 350 W. 800 N. SUITE 214 SALT LAKE CITY UT 84103 (801) 736-0729
PROLUNG INC (Filer) CIK: 0001541884 (see all company filings)

IRS No.: 201922768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38362 | Film No.: 21742763
SIC: 3841 Surgical & Medical Instruments & Apparatus
Office of Life Sciences